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Abstract
The discriminative stimulus properties of ethanol are mediated in part by positive modulation of
GABAA receptors. Recent evidence indicates that metabotropic glutamate receptor subtype 5
(mGluR5) activity can influence GABAA receptor function. Therefore, the purpose of this work was
to examine the potential involvement of mGluR5 in the discriminative stimulus effects of ethanol.
In rats trained to discriminate ethanol (1 g/kg, intragastric gavage (i.g.)) from water, 2-methyl-6-
(phenylethyl)-pyridine (MPEP) (1–50 mg/kg, i.p.) a selective noncompetitive antagonist of the
mGlu5 receptor did not produce ethanol-like stimulus properties. However, pretreatment with MPEP
(30 mg/kg) reduced the stimulus properties of ethanol as indicated by significant reductions in
ethanol-appropriate responding, specifically at 0.5 and 1 g/kg ethanol, and a failure of ethanol test
doses (1 and 2 g/kg) to fully substitute for the ethanol training dose. To test whether mGluR5
antagonism altered the GABAA receptor component of the ethanol stimulus, the ability of MPEP to
modulate pentobarbital and diazepam substitution for ethanol was assessed. Pentobarbital
substitution (1–10 mg/kg, i.p.) for ethanol was not altered by MPEP pretreatment. However, MPEP
pretreatment inhibited the ethanol-like stimulus properties of diazepam (5 mg/kg, i.p.). To examine
a potential anatomical basis for these pharmacological findings, expression patterns of mGluR5- and
benzodiazepine-sensitive GABAA α1-containing receptors were examined by dual-label fluorescent
immunohistochemistry with visualization by confocal microscopy. Results indicated that mGluR5-
and GABAA α1-containing receptors were both coexpressed in limbic brain regions and colocalized
on the same cells in specific brain regions including the amygdala, hippocampus, globus pallidus,
and ventral pallidum. Together, these findings suggest an interaction between mGluR5- and
benzodiazepine-sensitive GABAA receptors in mediating ethanol discrimination.
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INTRODUCTION
The amino-acid glutamate is the primary excitatory transmitter in the mammalian CNS. Fast
excitatory actions of glutamate are mediated by ionotropic glutamate receptor (iGluR) N-
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methyl-D-aspartate (NMDA), α-amino-3-hydroxi-5-methyl-ioxyzole-4-propionic acid, and
kainate receptors. Metabotropic glutamate receptors (mGluRs) mediate slower glutamate
responses through G-protein coupling to various intracellular signaling cascades that can
modulate, or fine-tune, iGluR function (Benquet et al, 2002). Eight mGluR subtypes (mGluR1–
8) have been cloned. These receptors have been classified into three groups based on amino-
acid sequence similarity, agonist pharmacology, and the signal transduction pathways to which
they couple. Group I mGluRs (mGluR1 and 5) upregulate Ca2+ cascades, whereas Group II
(mGluR2 and 3) and Group III (mGluR4 and 6–8) receptors are both negatively coupled to the
cAMP cascade but are distinguished by their differing agonist–antagonist profiles and sequence
homologies (Gereau and Conn, 1995).
The availability of selective pharmacological agents has quickly begun to reveal basic
functional roles of mGluR5. MGluR5 activation with a selective agonist (CHPG) elevates
glutamate release (Pintor et al, 2000) and augments NMDA-induced membrane depolarization
in striatal slices (Pisani et al, 2001). Other evidence indicates that mGluR5 contributes to
striatal synaptic plasticity since the mGluR5 selective antagonist, 2-methyl-6-(phenylethyl)-
pyridine (MPEP), decreased long-term depression at corticostriatal synapses (Sung et al,
2001). Other studies have found beneficial effects of mGluR5 antagonists in animal models of
anxiety, pain, and neurodegeneration (Bordi and Ugolini, 1999; Spooren et al, 2001).
Moreover, genetic and pharmacological data have started to reveal a role for mGluR5 in
addiction. For instance, morphine (10 mg/kg) conditioned reward is inhibited by MPEP (30
mg/kg) (Popik and Wrobel, 2002) but lower doses of MPEP do not alter morphine conditioned
place preference (McGeehan and Olive, 2003). Mice lacking the mGluR5 gene do not self-
administer cocaine and show no cocaine-induced increase in locomotor activity (Chiamulera
et al, 2001), indicating a significant role of mGluR5 in the behavioral effects of psychomotor
stimulants.
Many of the physiological, biochemical, and behavioral effects of ethanol are known to involve
iGluR function (Dodd et al, 2000; Mihic, 1999; Aschner et al, 2001; Woodward, 1999;
Tabakoff and Hoffman, 1993; Littleton et al, 2001; Weight et al, 1993; Costa et al, 2000). In
addition to its effects on iGluRs, however, ethanol also modulates general metabotropic
receptor activity as evidenced by its ability to reduce basal and stimulated phosphoinositide
hydrolysis (Gonzales et al, 1986). Low concentrations of ethanol selectively alter neuronal
firing rates (Netzeband and Gruol, 1995) and Ca2+ levels (Gruol et al, 1997) mediated by
mGluRs in vitro. Chronic exposure to ethanol reduces mGluR1 mRNA levels in cerebellar
Purkinje neurons of mice (Simonyi et al, 1996) and early withdrawal from ethanol leads to
alterations in mGluR-evoked Ca2+ signaling in cerebellar neurons (Netzeband et al, 2002).
Moreover, pharmacologically relevant concentrations of ethanol inhibit glutamate-induced
Ca2+-dependent Cl− currents in Xenopus oocytes expressing mGluR5, but have no effect on
currents in oocytes expressing mGluR1 (Minami et al, 1998), suggesting that ethanol may
selectively alter mGluR5 function. In addition, the mGluR5 antagonist MPEP reduces the
reinforcing properties of ethanol (Sharko et al, 2002), and reduces alcohol relapse to alcohol
self-administration in two animal models (Bäckström et al, 2004).
In addition to their reinforcing properties, drugs of abuse produce distinctive subjective (ie
discriminative stimulus) effects that are an important determinant of abuse liability (Stolerman,
1992). Using differential reinforcement methods, drug discrimination experiments involve
training animals (eg pigeons, mice, rats, gerbils, monkeys, humans) to emit one response (ie a
lever press) after being injected with one dose of drug (ie called the training drug or training
dose). Thus, reinforcement (food or sucrose) is contingent on selecting the ‘correct’ or ‘drug-
appropriate’ lever. An alternative response (ie pressing a different lever) results in
reinforcement after vehicle injection. Once this discriminated performance is established, other
doses of the training drug, or other drugs, are administered to determine if they engender
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responding on the drug-appropriate lever. The extent to which a novel dose, or novel drug,
produces responding on the lever associated with the training drug is called drug ‘substitution’
or ‘generalization.’ The interpretation of these results is that a drug that produces high levels
of responding on the lever associated with the training drug (ie ethanol) has similar subjective
properties and acts by similar neurobiological mechanism(s) (Grant and Colombo, 1993;
Kostowski and Bienkowski, 1999). Novel drugs can also be tested for pharmacological
potentiation or antagonism of the discriminative stimulus effects of the training drug by
conducting pretreatment experiments (Besheer et al, 2003).
The discriminative stimulus effects of ethanol are mediated at least by GABAA receptors. For
example, positive modulators of GABAA receptors, such as barbiturates, benzodiazepines, and
neurosteroids, produce ethanol-like stimulus effects (Ator et al, 1993; Barry, 1991; Evans and
Balster, 1991; Grant et al, 1996, 1997; Jarbe and McMillan, 1983; Shelton and Grant, 2002)
in multiple species. MGluR5 activity has the potential to influence ethanol discrimination based
on evidence that mGluR5 can influence GABA neurotransmission (de Novellis et al, 2003;
Hoffpauir and Gleason, 2002; Diaz-Cabiale et al, 2002). For example, the mGluR5 agonist
CHPG has been shown to increase GABA levels in vivo and antagonism of mGlu5 receptors
blocks the CHPG-induced increases in GABA (de Novellis et al, 2003). In cultured amacrine
cells, GABA-gated currents are enhanced by CHPG administration, an enhancement that is
likely due to postsynaptic GABAA receptors (Hoffpauir and Gleason, 2002). MGlu5 receptors
are abundant in limbic brain regions such as the nucleus accumbens, cortex, and hippocampus
(Bordi and Ugolini, 1999; Spooren et al, 2001; Romano et al, 1995), where GABAA receptors
are known to modulate ethanol discrimination. For example, site-specific infusion of
GABAA-positive modulators such as muscimol, pentobarbital, or allopregnanolone in the
nucleus accumbens or amygdala substitute fully for systemic ethanol (Besheer et al, 2003;
Hodge and Cox, 1998; Hodge et al, 2001). It is plausible, therefore, that mGlu5 receptors might
regulate ethanol discrimination via modulation of GABAA receptor function.
Thus, the purpose of this study was to determine the potential involvement of mGluR5 in the
modulation of the discriminative stimulus effects of ethanol. In rats trained to discriminate (1
g/kg) ethanol from water, MPEP a noncompetitive antagonist of the mGlu5 receptor (Gasparini
et al, 1999) was assessed for its ability to substitute for ethanol and to modulate ethanol
discrimination. Further, the ability of MPEP to modulate pentobarbital and diazepam
substitution for ethanol was assessed. Finally, to examine the potential anatomical basis for an
interaction between mGlu5 and GABAA receptors, expression patterns of these receptors were
examined using dual-label florescent immunohistochemistry with confocal visualization.
METHOD
Animals
In all, 12 male Long Evans rats (Harlan Sprague–Dawley, Indianapolis, IN) weighing 150–
200 g upon arrival to the colony were individually housed in Plexiglas cages. Rats were handled
and weighed daily for 2 weeks before lever press training began. Once rats reached a body
weight of approximately 300 g, rats were fed 16 g of food daily for the remainder of the 12-
month study (weights maintained at approximately 325 g). Water was available continuously
in the home cage. The colony room was maintained on a 12-h light/dark cycle and experiments
were conducted during the light portion of the cycle. Animals were under continuous care and
monitoring by veterinary staff from the Division of Laboratory Animal Medicine (DLAM) at
UNC-Chapel Hill, which is accredited by the Association for the Assessment and Accreditation
of Laboratory Animal Care International (AAALAC). DLAM staff considered all of the rats
to be healthy throughout the course of the experiment, indicating that the procedures produced
no adverse affects on animal health or well-being. All procedures were also carried out in
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accordance with the NIH Guide to Care and Use of Laboratory Animals and institutional
guidelines.
Apparatus
Operant chambers (Med Associates, Georgia, VT) measuring 31 × 32 × 24 cm3 were used for
discrimination sessions. The chambers were located within sound-attenuating cubicles and
equipped with an exhaust fan that provided ventilation and masked external sounds. Two
response levers were located on the right wall of each chamber. Responses on the levers
activated a liquid dispenser centered between the levers that presented fluid in a 0.1 ml dipper
cup for 4 s during each operation. A stimulus light was located above each response lever and
was activated each time a reinforcer was delivered. The chambers were illuminated by an 8-
W light located on the left wall 28 cm above the floor. The chambers were interfaced (Med
Associates) to a computer that was programmed to control sessions and record data.
Procedure
Lever press training—Rats were trained to lever press on a fixed ratio 1 (FR1) schedule of
reinforcement in overnight sessions. That is, a single lever press on either of the two levers
resulted in presentation of 0.1 ml of a liquid sucrose solution (10% (w/v)). After three overnight
sessions, 1 h lever press training began. During these sessions, rats were placed in the chamber
for 10 min before the house light was illuminated and either the right or the left lever was
extended into the chamber and signaled the beginning of the session. The presentation of the
right and left lever was alternated each day and the schedule of reinforcement was gradually
increased to FR10. That is, once 10 lever presses occurred, the sucrose was presented for 4 s.
Rats received equal experience with both levers at each reinforcement schedule. Discrimination
training began once responding on the FR10 schedule was stable (<10% daily variation in the
total number of responses).
Discrimination training—Training sessions were conducted 5 days per week (M–F) during
which ethanol (1 g/kg) or water was administered by intragastric gavage (i.g.) prior to the start
of the 15-min sessions. Immediately following the ethanol or water administration, the rats
were placed in the chambers. Similar to lever press training sessions, after 10 min the house
light was illuminated and both levers were introduced into the chamber signaling the beginning
of the session. Following ethanol administration, completion of 10 responses on the ethanol-
appropriate lever resulted in the presentation of the sucrose solution. Similarly, following water
administration, completion of 10 responses on the water-appropriate lever resulted in sucrose
delivery. During both the ethanol and water sessions, responses on the inappropriate lever were
recorded but produced no programmed consequences. The lever associated with ethanol or
water administration was randomly assigned and counterbalanced across animals. Water and
ethanol training days varied on a double alternation schedule (W, W, E, E, etc.). The training
sessions continued until the percentage of ethanol- and water-appropriate lever press responses
emitted prior to the first reinforcer, and during the entire session was >80% for 10 consecutive
days. Once these criteria were met, testing began.
Testing procedures—Test sessions were identical to the training sessions, except that they
were 2 min in duration, and completion of an FR10 on either lever resulted in sucrose delivery.
Reinforcement was delivered during test sessions to assess the possible effects of test
treatments on overall response rates. These test sessions were interspersed with training
sessions only if performance during the previous five training sessions met the accuracy
criteria. If the criteria were not met, training continued until response accuracy was >80% for
5 consecutive days, consequently, not all rats were used in each test condition.
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Ethanol substitution—In four different test sessions, various ethanol doses (0.1, 0.5, 1, and
2 g/kg, i.g.) were administered to determine an ethanol substitution curve. Rats (n = 12) received
each ethanol dose in a random order.
MPEP substitution—To test whether MPEP would substitute for ethanol, rats (n = 6) were
administered MPEP (0, 1, 10, 30, and 50 mg/kg, i.p.) 20 min before receiving a water gavage
and were then placed in the chambers. Each MPEP dose was administered once in random
order.
Ethanol substitution with MPEP pretreatment—In order to evaluate the effects of
MPEP pretreatment on the stimulus effects of multiple ethanol doses, rats (n = 8) were
administered MPEP (30 mg/kg, i.p.) or saline 20 min before ethanol (0.1, 0.5, 1, and 2 g/kg,
i.g.). Rats were tested once on each pretreatment combination and the combinations were tested
randomly.
GABAA-positive modulator substitution with MPEP pretreatment—Saline or
MPEP (30 mg/kg, i.p.) was administered 20 min before pentobarbital injection (1, 3, and 10
mg/kg, i.p.). Rats (n = 10) were tested once on each pretreatment combination and the
combinations were tested randomly. After pentobarbital testing, saline or MPEP (30 mg/kg,
i.p.) was administered 20 min before diazepam injection (1, 3, and 5 mg/kg, i.p.). Rats (n = 11)
were tested once on each pretreatment combination and the combinations were tested
randomly. Gavage was withheld during these tests.
Drugs
Ethanol (95% (w/v)) was diluted in distilled water to a concentration of 20% (v/v) and was
administered i.g. in various volumes to obtain doses of 0.1, 0.5, 1, and 2 g/kg. A corresponding
volume of water to the 1 g/kg ethanol training dose was used. Pentobarbital (Sigma-Aldrich,
St Louis, MO) was dissolved in saline, and injected i.p. at a volume of 1 ml/kg. MPEP (Sigma)
was also dissolved in saline by gently heating the solution and injected i.p. at a volume of 1
ml/kg, except for the 50 mg/kg dose, which was injected at a volume of 2 ml/kg. Diazepam
(Sigma) in a suspension of 1% carboxymethylcellulose was injected i.p. at a volume of 2 ml/
kg.
Data Analysis
Response accuracy was expressed as the percentage of ethanol-appropriate lever presses upon
delivery of the first reinforcer. Response rate (responses/min) was analyzed for the entire
session and provided an index of locomotor ability. Complete substitution for the ethanol
stimulus was defined as >80% choice of the ethanol lever upon completion of the first FR10
during test sessions. If an animal did not complete an FR10 during these test sessions, then that
animal was not included in the response accuracy analysis, but was included in the response
rate analysis. The left-most panels of each figure show the percentage of ethanol-appropriate
lever responding on completion of the first FR10 and response rate during the ethanol and
water session that preceded testing of that drug combination. One or two-way repeated
measures analysis of variance (ANOVA) were used to analyze response accuracy and response
rate data. Planned comparisons were made within each pretreatment condition (eg each
diazepam dose compared to lowest diazepam dose in the saline pretreatment condition), and
between the pretreatment conditions at each test drug dose (eg responses after saline and MPEP
compared at each diazepam dose). ED50 values for the dose effects were determined by log-
dose probit analysis when possible, and paired t-tests were used to compare the ED50’s for the
ethanol, pentobarbital, and diazepam tests.
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At the conclusion of the ethanol discrimination study, the animals (n = 10) were deeply
anesthetized with pentobarbital (100 mg/kg, i.p.) and perfused transcardially with 0.1 M
phosphate-buffered saline (PBS) followed by 4% paraformaldehyde. The brains were removed
from the skull and placed in the same fixative solution for at least 24 h before being washed
with PBS and sliced on a vibratome into 40 µm sections. Primary antibodies used in the study
were a rabbit polyclonal antibody raised against mGluR5 (Neuromics, Northfield, MN; dilution
1:300) and a guinea-pig polyclonal antibody raised against GABAA α1-subunit (courtesy of
Dr Jean-Marc Fritschy; dilution 1:300). The fluorescent-coupled secondary antibodies were
Alexa Fluor® 488 goat anti-rabbit IgG (1:200 dilution) for mGluR5 and Alexa Fluor® 594 goat
anti-guinea pig IgG (1:200 dilution) for GABAA α1 (Molecular Probes, Eugene, OR, USA).
Visualization was performed using a Zeiss 410 laser-scanning confocal microscope (Carl Zeiss,
Oberkochen, Germany). Images were saved in tagged image format and exported to Adobe
Photoshop CS (Adobe Systems, Mountain View, CA) for analysis.
RESULTS
Ethanol Substitution
The left-most panels of Figure 1a and b show the percentage of ethanol-appropriate lever
responding on completion of the first FR10 and response rate during the ethanol and water
session that preceded testing of the ethanol dose response. Responding on the ethanol-
appropriate lever during the ethanol session was approximately 96% and less than 2% on the
water session. The percentage of ethanol-appropriate responses increased significantly as a
function of ethanol test dose (F(3,47) = 52.31, p<0.001), indicating that the procedures
established reliable stimulus control. Both the 1 and 2 g/kg test doses of ethanol substituted
fully for the 1 g/kg training dose (Figure 1a), with an ED50 value of 0.56 g/kg (±0.06 SEM).
The training dose (1 g/kg) did not affect response rate (Figure 1b). However, a significant
reduction in lever press responding was observed (F(3,47) = 5.85, p = 0.003), with the highest
dose (2 g/kg) suppressing responding relative to the lowest dose tested.
MPEP Substitution
As shown in Figure 2a, MPEP did not substitute for the stimulus effects of 1 g/kg ethanol (F
(4,20) = 1.58, p = 0.22). All MPEP doses tested failed to substitute for ethanol. The highest
MPEP dose tested (50 mg/kg) reduced response rate relative to saline (F(4,20) = 2.91, p =
0.047).
Ethanol Substitution with MPEP Pretreatment
Figure 3a shows the ethanol dose–response curve following saline and MPEP pretreatment.
MPEP pretreatment at the 1 and 2 g/kg ethanol doses includes seven animals due to the death
of one animal before testing was completed. Similar to the previous ethanol dose–response
curve presented in Figure 1a, dose-dependent substitution for the ethanol training dose (1 g/
kg) was observed. This dose-dependent substitution was inhibited by MPEP pretreatment. The
two-way repeated measures ANOVA revealed a main effect of ethanol dose (F(3,21) = 20.57,
p<0.001). After saline pre-treatment, ethanol-appropriate responding was greater at every
ethanol dose (0.5, 1, and 2 g/kg) relative to the 0.1 g/kg ethanol dose, p’s <0.03. MPEP
pretreatment significantly altered this pattern of responding, as only the highest ethanol dose
(2 g/kg) produced significantly greater ethanol-appropriate responding than the 0.1 g/kg
ethanol dose, p = 0.002. There was a significant main effect of pretreatment injection (F(1,7)
= 15.37, p = 0.005). MPEP pretreatment significantly reduced ethanol-appropriate responding
at the 0.5 and 1 g/kg ethanol doses, p’s <0.001. The ethanol dose by pretreatment injection
interaction was also significant, (F(3,19) = 4.62, p = 0.01). The mean ED50±SEM for ethanol
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substitution was 0.39±0.08 g/kg following saline pretreatment and 1.33±0.19 g/kg following
MPEP pretreatment. This 3.4-fold rightward shift in the ethanol dose–response curve was
significant, (t(3) = 5.4 p = 0.01).
As shown in Figure 3b, response rate was dose dependently reduced by ethanol (F(3,21) =
6.38, p = 0.003), with significant rate reductions observed at the highest ethanol dose (2 g/kg)
relative to the lowest dose (0.1 g/kg) after saline and MPEP pretreatment, p’s <0.02. The main
effect of pretreatment injection was also significant (F(1,7) = 7.58, p = 0.03), but no significant
interaction was observed. At the lowest ethanol dose tested (0.1 g/kg), response rate was
significantly lower after MPEP pretreatment, p = 0.02. MPEP did not induce a rate reduction
at any other ethanol dose. Taken together, MPEP pretreatment reduced ethanol-appropriate
responding, at doses that were not affected by response rate reductions (0.5 and 1 g/kg).
Pentobarbital Substitution for Ethanol with MPEP Pretreatment
Pentobarbital dose dependently substituted for ethanol as shown in Figure 4a. Two rats did not
complete a first FR when MPEP was administered before the highest pentobarbital dose (10
mg/kg). Consequently, those animals are not included in the response accuracy analysis (Figure
4a), but are included in the response rate analyses (Figure 4b). The two-way repeated measures
ANOVA revealed a main effect of pentobarbital dose (F(2,18) = 23.13, p<0.001), with the
highest pentobarbital dose (10 mg/kg) producing significantly greater responding on the
ethanol-appropriate lever than the lowest dose (1 mg/kg) after saline and MPEP pretreatment,
p’s<0.002. Pentobarbital substitution was not altered by MPEP pretreatment, as confirmed by
the lack of a significant main effect of pretreatment injection (F<1). The pentobarbital dose by
pretreatment injection interaction was also not significant (F<1). The mean±SEM ED50 for
pentobarbital substitution was 5.26±0.81 mg/kg following saline pretreatment and 4.89±0.85
mg/kg following MPEP pretreatment.
Response rate was significantly altered by pentobarbital dose (F(2,18) = 17.05, p<0.001), with
a significant reduction observed at the 10 mg/kg dose after saline and MPEP pretreatment,
p’s<0.001 (Figure 4b). Response rate was also reduced by MPEP pretreatment (F(1,9) = 15.46,
p = 0.003), and at each pentobarbital dose MPEP decreased responding relative to saline
pretreatment, p’s<0.03. The pentobarbital dose by pretreatment injection interaction was not
significant (F<1).
Diazepam Substitution for Ethanol with MPEP Pretreatment
Diazepam dose dependently substituted for ethanol as shown in Figure 5a. One animal died
before completion of the tests, and accordingly, the 1 mg/kg diazepam dose following MPEP
pretreatment includes data from 10 animals. The two-way repeated measures ANOVA revealed
a significant main effect of diazepam dose (F(2,20) = 4.94, p = 0.02). After saline pretreatment,
significantly greater responding on the ethanol-appropriate lever at the highest diazepam dose
(5 mg/kg) relative to the 1 mg/kg diazepam dose was evident, p = 0.002. This effect was
prevented by MPEP pretreatment. The main effect of pretreatment injection was not
significant; however, the diazepam dose by pretreatment injection interaction was significant
(F(2,19) = 3.72, p = 0.04). MPEP pretreatment reduced ethanol-appropriate responding at the
5 mg/kg diazepam dose relative to saline pretreatment, p = 0.01. The mean± SEM ED50 for
diazepam substitution was 2.23±0.21 mg/kg and was 2.03±70.26 mg/kg following MPEP
pretreatment. Given that MPEP pretreatment reduced diazepam substitution, the ED50
following MPEP pretreatment was determined from the data of five animals.
Figure 5b illustrates response rate for the diazepam substitution tests. There was a significant
main effect of diazepam dose (F(2,20) = 4.69, p = 0.02), with a response reduction observed
after saline pretreatment at the highest diazepam dose (5 mg/kg) relative to the lowest diazepam
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dose (1 mg/kg), p = 0.006. MPEP pretreatment also significantly reduced response rate (F(1,10)
= 11.14, p = 0.007); a significant reduction was observed at the 1 and 3 mg/kg diazepam doses.
The diazepam dose by pretreatment drug interaction was not significant. Thus, MPEP
pretreatment significantly reduced ethanol-appropriate responses at the 5 mg/kg diazepam
dose. A response rate reduction was observed at this dose after saline pretreatment; however,
MPEP pretreatment did not enhance that response rate reduction.
Immunohistochemistry with Confocal Microscopy
In order to determine if there is an anatomical basis for the pharmacological interaction between
BZ-sensitive GABAA receptors and mGlu5 receptors, dual-label fluorescent
immunohistochemistry with confocal microscopy was used to examine both the individual and
joint expression patterns of mGluR5 and GABAA receptors expressing the α1 molecular
subunit, which constitutes the majority of BZ-sensitive GABAA receptors (Mohler et al,
1997). Previous work has shown that GABAA α1 receptors and mGlu5 receptors are both
expressed in brain regions known to modulate ethanol discrimination such as the nucleus
accumbens, amygdala, and hippocampus (Romano et al, 1995; Hodge and Cox, 1998; Pirker
et al, 2000; Schwarzer et al, 2001; Besheer et al, 2003). In the shell and core (Figure 6a) of
the nucleus accumbens, relatively few cell bodies showed GABAA α1 immunoreactivity,
consistent with Härtig et al, (1995). Several GABAA α1-labeled processes were evident with
some processes visibly extending into the ventral pallidum. Consistent with the existing
literature, diffuse mGluR5 staining was observed throughout the striatum including the core
(Figure 6b) and shell regions of the nucleus accumbens. In the basolateral amygdala, moderate
mGluR5 and GABAA α1 immunoreactivity was found with labeled cell bodies and processes.
In the CA1, CA2, CA3, and dentate gyrus of the hippocampus, intense mGluR5 staining of
cell bodies and processes was evident (Figure 6e). GABAA α1 staining was also found on the
cell bodies and processes in the same regions of the hippocampal formation (Figure 6d). The
pallidal regions (ventral pallidum and globus pallidus) were also examined given that mGluR5
and GABAA α1 are expressed in those regions (Lu et al, 1999; Pirker et al, 2000; Schwarzer
et al, 2001; Poisik et al, 2003) and that activation of mGluR5 in the nucleus accumbens has
been shown to increase GABA levels in the ventral pallidum (Diaz-Cabiale et al, 2002),
suggesting a potential interaction between the two receptor systems in this brain area. In the
present work, intense staining of both GABAA α1 and mGluR5 was found on cell bodies and
processes in the ventral pallidum (Figure 6g and h) and the globus pallidus (Figure 6j and k).
The coexpression of mGluR5 and GABAA α1 on neurons within these brain regions has not
been examined previously. As illustrated in Figure 6f, i and l, mGluR5 and GABAA α1 were
coexpressed on cells in all of the limbic brain regions examined, except for the nucleus
accumbens (Figure 6c). Interestingly, the coexpression pattern was relatively consistent across
the other brain regions. That is, intense mGluR5 immunoreactivity appeared to be on the
nuclear membrane, whereas intense GABAA α1 staining was localized on cell surface
membrane receptors and processes.
DISCUSSION
The discriminative stimulus effects of ethanol are mediated in part by positive modulation of
GABAA receptor activity (Ator et al, 1993; Grant and Lovinger, 1995; Hodge and Cox,
1998; Kostowski and Bienkowski, 1999; Hodge et al, 2001; Shelton and Grant, 2002).
Evidence indicates that mGlu5 receptors can modulate GABAA receptor function (Awad et
al, 2000; Hoffpauir and Gleason, 2002) and extracellular GABA levels. Moreover, ethanol
inhibits glutamate-induced Ca2+-dependent Cl− currents in Xenopus oocytes expressing
mGluR5 (Minami et al, 1998). Together, these findings suggest that the GABAA receptor
component of ethanol’s stimulus effects may be modulated by mGluR5 activity.
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The purpose of this work was to examine the involvement of mGlu5 receptors in the
discriminative stimulus properties of ethanol. Long Evans rats were trained by differential
reinforcement to discriminate ethanol (1 g/kg, i.g.) from water vehicle using standard two-lever
operant drug discrimination procedures (Hodge and Cox, 1998; Hodge et al, 2001; Besheer et
al, 2003). The discrimination training procedures established reliable stimulus control as
ethanol dose dependently substituted for the training dose of ethanol (1 g/kg). Administration
of the selective mGluR5 antagonist MPEP (0–50 mg/kg) did not produce ethanol-like stimulus
effects when administered alone, as indicated by low ethanol-appropriate responding. The
highest dose of MPEP (50 mg/kg) significantly decreased response rate, which indicates that
the compound was behaviorally active in the dose range tested and supports previous studies
that found locomotor suppression by high doses of MPEP (Spooren et al, 2000). These data
demonstrate that antagonism of mGluR5 function alone was not sufficient to produce
discriminative stimulus properties that correspond to ethanol (1 g/kg).
A primary finding of the present study is that mGluR5 antagonism inhibited the discriminative
stimulus properties of ethanol. Under control conditions, test doses of ethanol (1 and 2 g/kg)
substituted fully (ie >80% ethanol-lever selection) for the discriminative stimulus properties
of the ethanol (1 g/kg) training dose. Following MPEP (30 mg/kg) pretreatment, these test
doses failed to fully substitute for the training dose. In addition, administration of MPEP prior
to test doses of ethanol shifted the ethanol substitution curve more than three-fold to the right.
This MPEP-induced shift in the ED50 for ethanol substitution was attributable to significant
reductions in ethanol-appropriate responding following ethanol (0.5 and 1 g/kg) test doses.
Reductions in response rate were seen only after combination of MPEP with the highest dose
of ethanol (2 g/kg) tested, indicating that the reduction in the discriminative stimulus properties
of ethanol was not associated with locomotor impairment. These results suggest that the
discriminative stimulus effects of ethanol may be mediated in part by mGluR5 function.
In order to determine if the mGluR5 antagonist reduced ethanol discrimination by altering the
GABAA receptor component of the ethanol stimulus, the effect of MPEP pretreatment on
pentobarbital and diazepam substitution for ethanol (1 g/kg) was examined. Consistent with
previous reports, pentobarbital (Ator et al, 1993; Grant et al, 1996; Hodge et al, 2001; Shelton
and Grant, 2002) and diazepam (Jarbe and McMillan, 1983; Ator et al, 1993; Kostowski and
Bienkowski, 1999; Green-Jordan and Grant, 2000; Shelton and Grant, 2002) dose dependently
substituted for the stimulus effects of ethanol. MPEP pretreatment did not alter pentobarbital
(1–10 mg/kg) substitution for ethanol. However, MPEP enhanced the response rate-reducing
effects of pentobarbital, indicating that the mGluR5 antagonist was behaviorally active and
able to modulate the motor effects of pentobarbital. Although a higher MPEP dose would most
likely further enhance the locomotor depressant effects of pentobarbital, rendering effects on
ethanol-appropriate responding difficult to interpret, it remains possible that a lower MPEP
dose may have altered pentobarbital substitution. Conversely, the ethanol-like stimulus
properties of diazepam (5 mg/kg) were significantly inhibited by 30 mg/kg MPEP pretreatment.
The ED50 for ethanol substitution by diazepam was not altered by MPEP administration. This
was due to the selective inhibition of ethanol-appropriate responding following only the highest
dose of diazepam (5 mg/kg) tested. MPEP did not alter response rate when coadministered
with diazepam, indicating that inhibition of the ethanol-like stimulus effects of diazepam was
not associated with motor impairment. Both pentobarbital and diazepam are positive
modulators of GABAA receptors, and consequently share a similar mechanism of action. That
is, both compounds potentiate the action of GABA at the GABAA receptor (Study and Barker,
1981; Steinbach and Akk, 2001; Skerritt and Macdonald, 1984). However, pentobarbital can
also directly gate the GABAA receptor in the absence of GABA (Serafini et al, 2000; Akk and
Steinbach, 2000; Bormann, 1988). Another difference between the two compounds is that
benzodiazepines, like diazepam, have specific binding sites on GABAA receptors (see later),
while a specific binding site(s) for the barbiturates, like pentobarbital, has not yet been
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determined (Serafini et al, 2000). Further, barbiturates have pharmacological actions on other
ligand-gated ion channel receptors such as neuronal nicotinic acetylcholine receptors and
inhibitory glycine receptors (for a review see Krasowski and Harrison, 1999). Thus, the lack
of an effect of MPEP pretreatment (30 mg/kg) on pentobarbital substitution for ethanol could
be due to nonspecific effects of pentobarbital. These findings suggest that the mGluR5
antagonist MPEP inhibited the discriminative stimulus effects of ethanol specifically by
reducing, or otherwise interfering with, the component of ethanol discrimination that is
mediated by benzodiazepine-sensitive GABAA receptors.
Evidence of an interaction between GABAA and mGlu5 receptors has been reported (Hoffpauir
and Gleason, 2002). In that study, the activity of GABAA receptors in retinal amacrine cells
was enhanced by mGluR5 activation, as evidenced by an increase in GABA-gated currents
after administration of CHPG, an mGluR5 agonist. The mGlu5 receptor has also been shown
to influence GABA levels. For example, using microdialysis techniques, de Novellis et al,
(2003) found that activation of mGluR5 by perfusion of CHPG through the dialysis probe
significantly enhanced extracellular levels of GABA in the periaquaductal gray of rats.
Similarly, intra-accumbens administration of CHPG increased GABA levels in the ventral
pallidum (Diaz-Cabiale et al, 2002). In both studies, MPEP pretreatment blocked the agonist-
induced increases in GABA levels. Clearly, mGlu5 receptors can influence GABA functioning,
a major mediating factor in the discriminative stimulus effects of ethanol. The MPEP-induced
reduction in the stimulus properties of ethanol, and the ethanol-like properties of diazepam,
may have been a result of altered GABAergic functioning by MPEP pretreatment. Given that
pentobarbital substitution for ethanol was not affected, BZ-sensitive GABAA receptors may
have been differentially affected by MPEP-induced alterations. To our knowledge, interaction
between BZ-sensitive GABAA and mGlu5 receptors has not been examined previously.
A majority of BZ-sensitive GABAA receptors with high affinity for diazepam include the
α1β2γ2-subunit combination. The α1β2γ2- and α1β2γ2-subunit combinations also express high
affinity for diazepam but are less abundant throughout the brain (McKernan and Whiting,
1996). The BZ-binding site is generally thought to exist on the α-subunit (Fuchs et al, 1988;
Stephenson et al, 1990). The GABAA α1-subunit is distributed in brain regions known to
modulate ethanol discrimination (eg nucleus accumbens, amygdala, hippocampus; Pirker et
al, 2000), as is the mGlu5 receptor (Romano et al, 1995), and these distribution patterns were
also found in the immunohistochemical studies of the present work. Further, we found that
mGluR5 and GABAA α1 were coexpressed on cell bodies in all of the limbic brain regions
examined, with the exception of the nucleus accumbens. The lack of coexpression in the
nucleus accumbens may be due to the relatively few GABAA α1 immunoreactive cell bodies,
and the diffuse nature of the mGluR5 staining in that brain region. Regardless, the consistent
pattern of coexpression on cells suggests that mGluR5- and GABAA α1-containing receptors
might interact at the brain regional level.
We also observed coexpression of mGlu5 and GABAA α1 receptors on the same cells in brain
regions that modulate the discriminative stimulus effects of ethanol such as the amygdala and
hippocampus (Hodge and Cox, 1998; Hodge et al, 2001; Besheer et al, 2003). Representative
cells from the hippocampus (CA3) are shown in Figure 6 (panel f). In those cells showing
coexpression, intense mGluR5 immunoreactivity appeared to be on the nuclear membrane,
whereas GABAA α1 was localized on the cell surface, or plasma membrane. This pattern of
mGluR5 nuclear membrane distribution is consistent with O’Malley et al (2003). In that study,
using confocal microscopy mGluR5 was colocalized with lamin B2, a nuclear membrane
marker. Accordingly, mGlu5 receptors expressed on nuclear membranes can produce sustained
oscillatory Ca2+ responses (O’Malley et al, 2003), which indicates that these receptors can
modulate intracellular signaling. This suggests that mGlu5 receptors might modulate
GABAA receptor function on specific cells via alterations in Ca2+ -linked second messenger
Besheer and Hodge Page 10













systems such as PKC (eg Hodge et al, 1999), which is a possible basis for the pharmacological
interaction between mGlu5 and GABAA receptors seen in the present work.
In addition to finding mGluR5 and GABAA α1 coexpression in brain regions known to
modulate ethanol discrimination, the same cellular coexpression pattern was also observed in
the ventral pallidum and the globus pallidus. Interestingly, GABAA α1 receptors in the ventral
pallidum are known to mediate ethanol self-administration (June et al, 2003), but the role of
pallidal regions in ethanol discrimination has not been examined. In the present study, both the
ventral pallidum and globus pallidus showed intense immunoreactivity for the GABAA α1-
subunit, which is consistent with previous findings that showed prominent expression of the
α1-subunit along with β2- and γ2-subunits (Schwarzer et al, 2001), and suggests that these
brain regions mediate pharmacological sensitivity to diazepam. Thus, the mGluR5 antagonist
tested in the present study may have inhibited both ethanol discrimination, and diazepam
substitution for ethanol, by modulating GABAA receptor function within pallidal regions.
Other evidence suggests that mGlu5 and GABAA receptors may interactively modulate neural
circuits among brain regions. For example, a majority of projection neurons from the nucleus
accumbens to the ventral pallidum express mGluR5 (Lu et al, 1999), suggesting that
GABAergic projections from the accumbens can be modulated by mGluR5 activity. Indeed,
infusion of the mGluR5 agonist CHPG into the nucleus accumbens increased GABA levels in
the ventral pallidum (Diaz-Cabiale et al, 2002). The nucleus accumbens plays a major role in
mediating the discriminative stimulus effects of ethanol. GABAA-positive modulators such as
muscimol and allopregnanolone, microinjected into the nucleus accumbens produce ethanol-
like stimulus properties (Hodge and Cox, 1998; Hodge et al, 2001; Besheer et al, 2003).
Therefore, there exists the possibility that the discriminative stimulus properties of ethanol are
mediated in part by GABAergic projection neurons from the nucleus accumbens to the pallidal
regions. Moreover, antagonism of mGluR5 in this pathway may have inhibited ethanol
discrimination and diazepam substitution for ethanol by altering GABA neurotransmission in
the ventral pallidum. Clearly, the potential role of nucleus accumbens projections and the
cellular interactions between mGluR5 and GABAA α1 in modulating the stimulus effects of
ethanol will need to be further examined. However, given the behavioral and
immunohistochemical findings of the present work and the existing literature, the foundation
exists to predict an interaction between mGluR5 and GABAA α1 receptors within limbic
circuits.
In conclusion, drugs of abuse produce distinctive subjective effects in humans that are often
described as ‘high’ or ‘euphoria’. These subjective effects play a major role in the onset and
maintenance of drug-taking behaviors (Stolerman, 1992). Thus, examination of the
discriminative stimulus effects of drugs is essential for the effective development of
therapeutics designed to aide in drug abuse-related disorders. Indeed, MPEP pretreatment has
been found to reduce the acute reinforcing effects of ethanol (Sharko et al, 2002) and relapse
to ethanol-seeking behavior (Bäckström et al, 2004), suggesting that targeting the mGlu5
receptor system may be a potential therapeutic strategy for the treatment of alcohol-related
disorders. The findings from the present work suggest a specific behavioral mechanism by
which MPEP may reduce ethanol reinforcement and relapse. That is, MPEP appears to reduce
the subjective (ie discriminative stimulus) properties of ethanol, which may contribute to
reductions in chronic drinking or excessive consumption during relapse. Moreover, the present
data indicate that MPEP does not substitute for the stimulus effects of ethanol, indicating
minimal coabuse liability. Further examination of potential interactions between ethanol’s
physiological and behavioral effects and the mGlu5 receptor system may indeed reveal the
mGluR5 system to be a novel and effective therapeutic target in the treatment of alcoholism.
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(a) Mean (±SEM) percentage of ethanol-appropriate responding upon completion of the first
FR10 at each ethanol dose tested (n = 12). (b) Mean (±SEM) test session response rate at each
ethanol dose tested. Data points to the left of the x-axis break represent performance on the
water (W) and ethanol (E) training session prior to testing. Data points to the right of the x-
axis break represent test session performance following IG ethanol administration. The
horizontal dashed line (>80%) represents full substitution for the discriminative stimulus
effects of ethanol (1 g/kg, i.g.). *Significant difference from 0.1 g/kg ethanol (Tukey’s,
p<0.05).
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(a) Mean (±SEM) percentage of ethanol-appropriate responding upon completion of the first
FR10 at each MPEP dose tested (n = 6). (b) Mean (±SEM) test session response rate at each
MPEP dose tested. Data points to the left of the x-axis break represent performance on the
water (W) and ethanol (E) training session prior to testing. Data points to the right of the x-
axis break represent test session performance following i.p. MPEP administration. The
horizontal dashed line (>80%) represents full substitution for the discriminative stimulus
effects of ethanol (1 g/kg, i.g.). *Significant difference from saline (Tukey’s, p<0.05).
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(a) Mean (±SEM) percentage of ethanol-appropriate responding upon completion of the first
FR10 after saline or MPEP pretreatment at each ethanol dose (n = 8). (b) Mean (±SEM) test
session response rate after saline or MPEP pretreatment at each ethanol dose tested. Data points
to the left of the x-axis break represent performance on the water (W) and ethanol (E) training
session prior to testing. The horizontal dashed line (>80%) represents full substitution for the
discriminative stimulus effects of ethanol (1 g/kg, i.g.). *Significantly different from the
respective 0.1 g/kg ethanol dose within pretreatment condition. †Significant difference between
saline and MPEP pretreatment (Tukey’s, p>0.05).
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(a) Mean (±SEM) percentage of ethanol-appropriate responding upon completion of the first
FR10 after saline or MPEP pretreatment at each pentobarbital dose tested (n = 10). (b) Mean
(±SEM) test session response rate after saline or MPEP pretreatment at each pentobarbital dose
tested. Data points to the left of the x-axis break represent performance on the water (W) and
ethanol (E) training session prior to testing. The horizontal dashed line (>80%) represents full
substitution for the discriminative stimulus effects of ethanol (1 g/kg, i.g.). *Significantly
different from the respective 1 mg/kg pentobarbital dose within pretreatment
condition. †Significant difference between saline and MPEP pretreatment (Tukey’s, p<0.05).
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(a) Mean (±SEM) percentage of ethanol-appropriate responding upon completion of the first
FR10 after saline or MPEP pretreatment at each diazepam dose tested (n = 11). (b) Mean
(±SEM) test session response rate after saline or MPEP pretreatment at each diazepam dose
tested. Data points to the left of the x-axis break represent performance on the water (W) and
ethanol (E) training session prior to testing. The horizontal dashed line (>80%) represents full
substitution for the discriminative stimulus effects of ethanol (1 g/kg, i.g.). *Significantly
different from the respective 1 mg/kg diazepam dose within pretreatment
condition. †Significant difference between saline and MPEP pretreatment (Tukey’s, p<0.05).
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Confocal images from a representative rat showing the α1-subunit of the GABAA receptor and
mGluR5 in the core of the nucleus accumbens (AcbC; a–c), the CA3 region of the hippocampus
(CA3; d–f), the ventral pallidum (VP; g–i), and the globus pallidus (GP; j–l). GABAA α1
labeling appears in red, and mGluR5 labeling appears in green. Images a–i taken at × 63
magnification; images j–l taken at × 40 magnification.
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